Response: Re: Adjuvant treatment of high-risk, radically resected rastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial [5]

Stefano Cascinu; Mario Scartozzi; Carlo Barone; Roberto Labianca; Armando Santoro; Carlo Carnaghi; Giordano D. Beretta; Vincenzo Catalano; Sandro Barni; Luciano Frontini

doi:10.1093/jnci/djm094

Response: Re: Adjuvant treatment of high-risk, radically resected rastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial [5]

Stefano Cascinu, Mario Scartozzi, Carlo Barone, Roberto Labianca, Armando Santoro, Carlo Carnaghi, Giordano D. Beretta, Vincenzo Catalano, Sandro Barni, Luciano Frontini

Istituto Clinico Humanitas

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	1346-1347
Number of pages	2
Journal	Journal of the National Cancer Institute
Volume	99
Issue number	17
DOIs	https://doi.org/10.1093/jnci/djm094
Publication status	Published - Sep 5 2007

ASJC Scopus subject areas

Cancer Research
Oncology

Access to Document

10.1093/jnci/djm094

Cite this

Cascinu, S., Scartozzi, M., Barone, C., Labianca, R., Santoro, A., Carnaghi, C., Beretta, G. D., Catalano, V., Barni, S., & Frontini, L. (2007). Response: Re: Adjuvant treatment of high-risk, radically resected rastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial [5]. Journal of the National Cancer Institute, 99(17), 1346-1347. https://doi.org/10.1093/jnci/djm094

Response : Re: Adjuvant treatment of high-risk, radically resected rastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial [5]. / Cascinu, Stefano; Scartozzi, Mario; Barone, Carlo; Labianca, Roberto; Santoro, Armando; Carnaghi, Carlo; Beretta, Giordano D.; Catalano, Vincenzo; Barni, Sandro; Frontini, Luciano.

In: Journal of the National Cancer Institute, Vol. 99, No. 17, 05.09.2007, p. 1346-1347.

Research output: Contribution to journal › Article › peer-review

Cascinu, S, Scartozzi, M, Barone, C, Labianca, R, Santoro, A, Carnaghi, C, Beretta, GD, Catalano, V, Barni, S & Frontini, L 2007, 'Response: Re: Adjuvant treatment of high-risk, radically resected rastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial [5]', Journal of the National Cancer Institute, vol. 99, no. 17, pp. 1346-1347. https://doi.org/10.1093/jnci/djm094

Cascinu S, Scartozzi M, Barone C, Labianca R, Santoro A, Carnaghi C et al. Response: Re: Adjuvant treatment of high-risk, radically resected rastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial [5]. Journal of the National Cancer Institute. 2007 Sep 5;99(17):1346-1347. https://doi.org/10.1093/jnci/djm094

Cascinu, Stefano ; Scartozzi, Mario ; Barone, Carlo ; Labianca, Roberto ; Santoro, Armando ; Carnaghi, Carlo ; Beretta, Giordano D. ; Catalano, Vincenzo ; Barni, Sandro ; Frontini, Luciano. / Response : Re: Adjuvant treatment of high-risk, radically resected rastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial [5]. In: Journal of the National Cancer Institute. 2007 ; Vol. 99, No. 17. pp. 1346-1347.

@article{53037b31e75946bab9e87b00abef86a9,

title = "Response: Re: Adjuvant treatment of high-risk, radically resected rastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial [5]",

author = "Stefano Cascinu and Mario Scartozzi and Carlo Barone and Roberto Labianca and Armando Santoro and Carlo Carnaghi and Beretta, {Giordano D.} and Vincenzo Catalano and Sandro Barni and Luciano Frontini",

year = "2007",

month = sep,

day = "5",

doi = "10.1093/jnci/djm094",

language = "English",

volume = "99",

pages = "1346--1347",

journal = "Journal of the National Cancer Institute",

issn = "0027-8874",

publisher = "Oxford University Press",

number = "17",

}

TY - JOUR

T1 - Response

T2 - Re: Adjuvant treatment of high-risk, radically resected rastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial [5]

AU - Cascinu, Stefano

AU - Scartozzi, Mario

AU - Barone, Carlo

AU - Labianca, Roberto

AU - Santoro, Armando

AU - Carnaghi, Carlo

AU - Beretta, Giordano D.

AU - Catalano, Vincenzo

AU - Barni, Sandro

AU - Frontini, Luciano

PY - 2007/9/5

Y1 - 2007/9/5

UR - http://www.scopus.com/inward/record.url?scp=34548583393&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548583393&partnerID=8YFLogxK

U2 - 10.1093/jnci/djm094

DO - 10.1093/jnci/djm094

M3 - Article

AN - SCOPUS:34548583393

VL - 99

SP - 1346

EP - 1347

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

SN - 0027-8874

IS - 17

ER -

Response: Re: Adjuvant treatment of high-risk, radically resected rastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial [5]

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this